updating data

docs/SymptomsCausedByDrugs/data/ProportionalReportingRatios/vaccines/242.json

@@ -1 +1 @@
-{"Acute myeloid leukaemia": 42.75859542468945, "Acute respiratory distress syndrome": 3.9642173008982144, "Anaemia": 2.310907027196997, "Aspergillus infection": 17.246744755243064, "B-cell lymphoma recurrent": 235.7076294463422, "BK virus infection": 25.8132013532908, "Bacteraemia": 11.825149944179778, "Bacterial infection": 9.056731761608964, "Blood lactate dehydrogenase increased": 8.406682324824763, "Bone lesion": 62.60948007864048, "Bronchopulmonary aspergillosis": 16.246830411481817, "Candida infection": 5.469791678663731, "Clostridium difficile colitis": 11.386443904039048, "Colitis": 7.993067130491874, "Cystitis haemorrhagic": 15.226128801722451, "Cytomegalovirus infection": 5.424477503338146, "Cytomegalovirus infection reactivation": 42.78955912100677, "Cytopenia": 24.784157386503143, "Diffuse large B-cell lymphoma": 31.67731317669775, "Diffuse large B-cell lymphoma recurrent": 205.6403978976627, "Diffuse large B-cell lymphoma refractory": 69.82304652318464, "Disease progression": 23.759761268715145, "Disease recurrence": 8.6425599556636, "Enteritis": 33.228963411339805, "Epstein-Barr virus infection reactivation": 30.197945431269453, "Febrile neutropenia": 36.17453827670129, "Fungal infection": 7.795338135475069, "Gastric cancer": 7.934386489609373, "Gastrointestinal toxicity": 20.46131854364733, "Graft versus host disease": 19.98814560118569, "Granulocytopenia": 6.744459938897255, "Haematotoxicity": 91.91135750287236, "Hepatic cyst": 29.015323312332637, "Hepatitis B reactivation": 15.516634258955971, "Hepatitis acute": 6.311460372249967, "Hepatotoxicity": 4.956630564305426, "Hodgkin's disease": 33.858763843380395, "Hodgkin's disease recurrent": 575.0677120621181, "Ill-defined disorder": 4.719764665112564, "Infection": 3.252099430036429, "Intentional product use issue": 3.608205769563999, "JC virus infection": 126.61304747228668, "Kaposi's sarcoma": 40.38646349054193, "Klebsiella bacteraemia": 173.3695267637119, "Lymphoma": 18.73150043133445, "Lymphopenia": 7.681563915256989, "Malignant neoplasm progression": 2.3766976935474866, "Mantle cell lymphoma recurrent": 533.6099424136872, "Metastatic lymphoma": 162.38853222426616, "Mucosal inflammation": 34.98697437223768, "Myelodysplastic syndrome": 81.4027984094622, "Myelodysplastic syndrome with excess blasts": 187.05989123202315, "Myelosuppression": 3.967085255369893, "Nephropathy toxic": 4.777767750232702, "Neuropathy peripheral": 2.338452565873178, "Neutropenia": 4.235681698556986, "Neutropenic sepsis": 42.005298328183, "Neutrophil count decreased": 2.2197928452518907, "Non-Hodgkin's lymphoma": 56.93476936728541, "Non-Hodgkin's lymphoma recurrent": 567.372300187744, "Off label use": 4.776783221345876, "Pancytopenia": 10.547358989551524, "Plasma cell myeloma": 2.309216098104557, "Pneumocystis jirovecii pneumonia": 20.318614157098374, "Pneumonia": 2.675826417987213, "Pneumonitis": 8.776898531720585, "Polychromasia": 281.1710476480148, "Post transplant lymphoproliferative disorder": 32.85664997954095, "Product use in unapproved indication": 2.631025605959052, "Progressive multifocal leukoencephalopathy": 35.32857658513915, "Pulmonary toxicity": 8.267271925146948, "Respiratory failure": 2.6019668964575198, "Second primary malignancy": 38.05057265653156, "Sepsis": 4.959299852254206, "Septic shock": 5.833560595534096, "Staphylococcal infection": 3.13841633132439, "Stomatitis": 4.7923938226571625, "Systemic mycosis": 76.24867406233687, "Therapy non-responder": 2.8683689590671784, "Therapy partial responder": 13.8483616178848, "Thrombocytopenia": 7.872387953443818, "Venoocclusive liver disease": 58.05605697475786}
+{"actinic keratosis": 148.26, "acute myocardial infarction": 2.37, "amnesia": 2.32, "angina pectoris": 2.43, "anxiety": 2.01, "arrhythmia": 2.25, "atrial fibrillation": 2.92, "back pain": 3.68, "basal cell carcinoma": 41.95, "benign prostatic hyperplasia": 14.96, "blindness": 8.28, "blindness transient": 12.92, "blindness unilateral": 11.88, "cataract": 2.23, "cerebrovascular accident": 3.01, "coronary artery disease": 3.21, "coronary artery occlusion": 3.96, "counterfeit product administered": 52.93, "cyanopsia": 78.61, "deafness": 16.42, "deafness neurosensory": 23.89, "deafness unilateral": 29.86, "depression": 2.14, "diplopia": 2.28, "drug ineffective": 2.76, "drug interaction": 2.77, "dyspepsia": 4.85, "emotional distress": 4.11, "erectile dysfunction": 6.35, "erection increased": 95.68, "expired product administered": 3.68, "eye haemorrhage": 4.77, "flushing": 3.35, "gastrooesophageal reflux disease": 3.97, "glaucoma": 4.06, "haematospermia": 66.64, "haemorrhagic stroke": 4.0, "hernia": 5.54, "hypoacusis": 4.0, "intentional product misuse": 5.44, "intraocular pressure increased": 4.21, "ischaemic stroke": 3.02, "lentigo maligna": 448.51, "loss of consciousness": 2.03, "macular degeneration": 3.79, "macular oedema": 7.07, "maligt melanoma": 339.44, "maligt melanoma in situ": 1150.54, "maligt melanoma stage i": 3635.72, "maligt melanoma stage ii": 2501.57, "maligt melanoma stage iii": 1168.9, "maligt melanoma stage iv": 877.28, "melanocytic naevus": 15.65, "melanoma recurrent": 117.92, "metastatic maligt melanoma": 139.71, "myocardial infarction": 4.93, "nasal congestion": 5.57, "ocular discomfort": 2.97, "ocular hyperaemia": 3.73, "optic ischaemic neuropathy": 95.78, "papilloedema": 6.11, "parkinson's disease": 2.56, "penile erythema": 54.02, "penile haemorrhage": 61.87, "penile swelling": 63.54, "penis disorder": 20.77, "photopsia": 3.8, "priapism": 233.7, "prostate cancer": 2.24, "prostatic specific antigen increased": 4.32, "prostatitis": 13.26, "prostatomegaly": 16.88, "retinal detachment": 8.29, "retinal haemorrhage": 3.97, "retinal vein occlusion": 15.08, "sleep apnoea syndrome": 4.29, "spontaneous penile erection": 106.92, "squamous cell carcinoma": 38.46, "sudden hearing loss": 28.13, "suspected counterfeit product": 21.03, "syncope": 2.61, "testicular swelling": 22.86, "tinnitus": 3.14, "transient global amnesia": 23.69, "transient ischaemic attack": 2.56, "vision blurred": 4.18, "visual field defect": 6.14, "visual impairment": 4.09, "wrong technique in product usage process": 6.89}